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A AB BS ST TR RA AC CT T
Postsurgical adhesion formation is a common but signif-
icant problem. This is the first clinical evaluation of a
new barrier material designed to reduce or eliminate
postsurgical adhesions. SprayGel™ can be delivered
laparoscopically or via laparotomy to form a strongly
adherent hydrogel film. In this multicenter study, we
evaluated the safety and effectiveness of SprayGel
absorbable adhesion barrier system in patients undergo-
ing open or laparoscopic myomectomy procedures.
Here, we discuss the results of our evaluation conducted
at the University of Kiel and Polyclinic of Bordeaux, and
assess some of the features of this novel adjunct to pre-
vent formation of postsurgical adhesions.
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I IN NT TR RO OD DU UC CT TI IO ON N
Adhesions are a major cause of chronic or recurrent
pelvic pain in a significant population of women1 and
are considered a major cause of infertility.1,2 It has been
estimated that as many as 50% to 90% of women who
have pelvic surgery for fertility enhancement will form
postsurgical adhesions.2,4 Because of the magnitude of
the problem, many approaches have been tested to pre-
vent or diminish adhesion formation, but attempts have
produced unequivocal results, and most recently, some
products that are particularly difficult to use, especially in
laparoscopic surgery.
SprayGel is an easy to apply, tissue adherent, synthetic
gel barrier that is absorbable and biocompatible.5 The
barrier is formulated to remain adherent to the site of
application for 5 to 7 days, then absorb completely via
hydrolysis.
The purpose of this study was to compare the effective-
ness and safety of SprayGel plus a good surgical tech-
nique (treatment group) with that of a good surgical
technique alone (control group) in the prevention of
postsurgical adhesions after uterine myomectomy.
M MA AT TE ER RI IA AL LS S   A AN ND D   M ME ET TH HO OD DS S
This study was conducted in accordance with the ICH
Harmonised Tripartite Guideline for Good Clinical
Practice, EN 540, ISO 14155, European Directive 95/
46/EEC, and all reviewing ethics committees. All poten-
tially eligible women scheduled to undergo conservative
surgery for leiomyoma or leiomyomatous uteri giving
written informed consent to participate in the study were
examined within 30 days prior to surgery, including
blood chemistries, hematological and coagulation param-
eters, and urinalysis.
At the time of the myomectomy procedure, the number,
severity, area and location (anterior, posterior, or fundus)
of adhesions were recorded during the original proce-
dure, along with location, size, and number of myomas
removed, and number and length of each uterine inci-
sion. Uterine incisions were closed in layers if subseros-
al, in 1 layer if superficial or pedunculated, with synthet-
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ic absorbable suture material, maximum size 3-0, and
suture tails trimmed. The surgeon was blinded to the
treatment assignment during the myomectomy proce-
dure. Upon completion of the myomectomy, but before
final closing, each patient was intraoperatively reassessed
to confirm continued eligibility for enrollment into the
study (ie, no other adhesion prevention products used,
no use of nonabsorbable sutures, no accidental enteroto-
my, no exposure to fluids other than Ringer’s lactate or
saline, etc) At that point, patients were randomly
assigned in a 1:1 ratio (treated:control) at each clinical
site, by opening sealed envelopes prepared prior to the
start of the study. For patients randomized to the treat-
ment group, the surgeon coated all suture lines and
potentially adhesiogenic surfaces on the uterus and adja-
cent structures with SprayGel. Thickness of the gel was
approximately 0.5 mm to 1.0 mm.
All patients were examined at discharge and at an in-office
visit 3 to 16 weeks after surgery immediately prior to a sec-
ond-look laparoscopic procedure (SLL). Patients were con-
tacted by phone 1 week after initial surgery to evaluate
their general health and occurrence of any adverse events.
The number, severity, and total area of adhesions were
recorded again during SLL performed 3 to 16 weeks after
the myomectomy, prior to any adhesiolysis.
R RE ES SU UL LT TS S
Fifty-one patients were enrolled in the study at the time
of this interim analysis. Five patients were not random-
ized: 2 served as training (initial) treatment patients, and
3 did not meet inclusion/exclusion criteria. One patient
was not included in analyses due to incomplete docu-
mentation. Of the remaining 45 patients, 24 were ran-
domized to treatment (T), and 21 were randomized to
untreated control (C). Eighteen of the 24 T patients
returned for SLL, and 13 C patients returned for SLL, at
the time of this interim analysis.
Treatment and control groups were similar ( (T Ta ab bl le e    1 1) ).
Most patients in this study had their procedure performed
laparoscopically (79% T, 76% C). No statistically signifi-
cant differences were observed between the 2 groups
with regard to leiomyoma removed or uterine incisions.
At the time of the initial procedure, patients randomized
to the treatment group had a higher incidence of pre-
existing adhesions (189% difference, ie, the treatment
group had 1.89 times the incidence that the control group
exhibited), severity (22% difference), and area (162% dif-
ference), than patients randomized to the control group.
Spray application of the adhesion barrier was straightfor-
ward, with minimal training required. Methylene blue in
the barrier simplified application and confirmed that tar-
get tissues were adequately coated. The product adhered
well to tissue allowing aggressive irrigation without dis-
lodging the barrier. Drains were used in a majority of
patients at 1 center (Kiel), which would have precluded
the use of regional instillates.
Although not all patients who had been enrolled at ini-
tial surgery returned for SLL (71% T, 52% C), no statisti-
cally significant differences were found between the
patients who did return and those who did not with
respect to surgery type, primary reason for surgery,
length of surgery, discharge exam, or 1-week clinic visit.
Primary efficacy outcomes were incidence (total number
of adhesions), severity (mean tenacity scores), and extent
(total area, cm2) of uterine adhesions seen during the
SLL. Despite the fact that treatment patients began with a
higher incidence of pre-existing adhesions, severity and
area, at SLL, they were 3.5 times more likely to be adhe-
sion-free: five of 18 treatment patients were adhesion-
free (28%), compared with 1 of 13 (8%) in the control
group ( (F Fi ig gu ur re e   1 1) ). The total number of adhesions was
27% less in the treatment group (P=NS), and mean adhe-
sion tenacity scores were significantly lower for the treat-
ment group (47% less, P=0.003). No evidence was pres-
T Ta ab bl le e   1 1. .
Patient Demographics
Treated Control
Randomized 24 21
Mean age 34.5 35.8
Mean weight,kg 65.1 62.7
Prior myomectomy 5(21%) 1(5%)
Primary cause
Infertility 10(42%) 8(38%)
Pain 7(29%) 8(38%)
Other 7(29%) 5(24%)
Leiomyoma removed
Mean number 3.1 2.9
Mean weight, g 124.5 112.1
Uterine incisions
Mean number 2.0 1.7
Mean length, cm 7.8 7.3
Completed SLL* 18 13
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ent of residual polymer, supporting the manufacturer’s
claim of complete barrier absorption.
When comparing SLL values with those of initial myomec-
tomy surgery, using initial measurements to correct for
baseline values, treated patients showed a decrease in
severity (P=0.0015), and a trend toward a decrease in total
area (P=NS) as shown in F Fi ig gu ur re es s   2 2 and 3 3. No adverse
events were related to the use of the SprayGel.
F Fi ig gu ur re e   1 1. . Percentage of patients with adhesions at second-look
laparoscopic procedure.
F Fi ig gu ur re e   2 2. . Change in adhesion severity from initial procedure to
second-look laparoscopic procedure.
F Fi ig gu ur re e   3 3. . Change in adhesion area from initial procedure to sec-
ond-look laparoscopic procedure.
C CO ON NC CL LU US SI IO ON NS S
SprayGel adhesion barrier was easy for the surgeon to
apply, adhering strongly to a variety of angled surfaces,
even in laparoscopic procedures. We found that the
material circumvented many of the problems associated
with earlier attempts to prevent adhesions, and although
this analysis focuses on a small population, the results
are very promising. This adhesion barrier system war-
rants further assessment in expanded populations of
patients undergoing pelvic procedures.
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